Sanofi Gets CDSCO Panel Nod To Market Avalglucosidase Alfa Powder for Pompe Disease Dr. Divya Colin28 Jan 2023 6:00 PM ISTNew Delhi: Granting a local Phase III and Phase IV clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug...
Sanofi plans to unveil blood disorder drug this year: Report Ruchika Sharma20 Jan 2023 2:30 PM ISTFrance: French drugmaker Sanofi SA plans to launch a drug for rare bleeding disorder hemophilia A this year, Chief Executive Officer Paul Hudson told...
USFDA accepts AstraZeneca’s BLA for Nirsevimab for prevention of RSV lower respiratory tract disease Ruchika Sharma7 Jan 2023 10:00 AM ISTRSV is a very contagious virus that can lead to serious respiratory illness, according to the Centers for Disease Control and Prevention.
Heartburn drug: Sanofi expects decision on Zantac dispute with Boehringer in Q1 at earliest Ruchika Sharma5 Jan 2023 1:15 PM ISTOriginally marketed by a forerunner of GSK, the medicine has been sold at different times by companies including Pfizer, Boehringer, and Sanofi as...
GSK, Sanofi, Pfizer and other drugmakers plan to raise prices on at least 350 drugs in US in January Ruchika Sharma31 Dec 2022 1:15 PM ISTTo date, Pfizer announced the most increases, with prices rising on 89 unique drug brands, and an additional increase on 10 drug brands at its Hospira...
US Federal Court assures safety from Ranitidine, dismisses 2,500 lawsuits alleging cancer linkage with drug Ruchika Sharma19 Dec 2022 3:48 PM ISTThe court ruling comes as a big win for pharmaceutical companies like Pfizer, Sanofi, GSK and Boehringer Ingelheim.
Sanofi gets EMA panel recommendation for Dupixent to treat eosinophilic esophagitis Ruchika Sharma19 Dec 2022 10:30 AM ISTEoE is a chronic, progressive inflammatory disease that damages the esophagus and prevents it from working properly.
Sanofi Dupixent gets European Commission nod for Prurigo Nodularis Ruchika Sharma18 Dec 2022 5:30 PM ISTParis: Regeneron Pharmaceuticals, Inc. and Sanofi have announced that the European Commission (EC) has expanded the marketing authorization for...
After Sanofi drops out of Horizon bid, Amgen emerges as frontrunner Ruchika Sharma12 Dec 2022 1:30 PM ISTSanofi said on Sunday that it was no longer in discussions with Horizon and does not intend to make an offer for it.
Cancer Litigation over Zantac: US Court gives relief to pharma cos, dismisses thousands of lawsuits Ruchika Sharma7 Dec 2022 1:10 PM ISTA Sanofi spokesperson said the decision "significantly decreases the scope of the litigation potentially by over 50%," with the remaining litigation...
Sanofi, JnJ, Amgen in talks to acquire Horizon Therapeutics Ruchika Sharma1 Dec 2022 4:33 PM ISTBengaluru: Horizon Therapeutics Plc said on Tuesday its board was engaged in highly preliminary discussions with three pharmaceutical giants for...
Britain regulator calls for review of reactions in eyes to Sanofi asthma drug Dupixent Ruchika Sharma30 Nov 2022 5:30 PM ISTEuropean and U.S. health regulators have listed conjunctivitis, an eye irritation that can cause redness and discomfort, as a side effect of Dupixent
